Register for the Xpert Alliance webcast, “Streamlining Biopharmaceutical Manufacturing: From Substance, to Product, to Patient”

Join us to discover how Rentschler Biopharma and Vetter are supporting a shared, shorter path to market for novel therapies.

Find out how two CDMOs are rethinking the value chain

As drug development grows increasingly complex and cost-intensive, biopharma companies are under pressure to shorten the path from drug substance, to drug product, to impactful therapy. To help these businesses accelerate the drug development process, Rentschler Biopharma and Vetter launched a collaboration – the Xpert Alliance – to develop aligned manufacturing approaches that enable our clients to bring new injectable medications to patients more easily and faster.

Woman holding a clinical drug product in a vial

What you’ll learn about our collaboration on these webcasts

Join us for one of these special presentations for insights on how our companies are mutually enhancing their services through complementary skills and experience. Discover how we’re working together to:

  • Simplify the drug manufacturing process
  • Accelerate key transitions and workflows
  • Optimize time-to-market for customers
  • Leverage synergies across the value chain

Choose your date to register

Meet our expert presenters

Two of our key client project leaders will share their insights on the goals and target impact of the Xpert Alliance.

Silke Zimmerman

Sr. Director, Client Program Management Office, Rentschler Biopharma


Silke’s lifelong interest in the natural sciences led her to train as a chemical engineer and she spent the early years of her career in the 1990s working on Interferon-beta and Interferon-gamma. She has been with Rentschler since 2007, during which time she has led more than 30 customer projects involving both niche biotech firms and major pharma companies. Her interest in business culminated in a business management diploma. After many year in a hybrid function as head of the project management office in parallel to being project leader Silke is now focused on her role as the head of client program management office

Ute Slotta

Customer Project Manager, Vetter


Ute studied biology at the Technical University of Munich, Germany. After gaining her PhD in biochemistry, she started her career in the biotechnology industry as head of formulation development and biochemistry. Her focus was on the development of recombinant spider silk proteins for multiple applications, including cosmetics and medical devices. In 2017, Ute decided to make a career change and joined Vetter’s customer project management team. In her role, she oversees and manages a wide variety of customer projects as well as strategic collaborations